DIMS Institute of Medical Science, Inc.

Developers of Medium-term Carcinogenesis Bioassays in the world. / Contract safety research facility.

Mission

HOME ≫ skin carcinogenesis ≫

Medium-term skin carcinogenesis bioassay

英語版 中期皮膚発がん性試験

Recently, development of new drug-form and additional indication are promoted for the life cycle management (LCM) in the pharmaceutical company. Medium-term skin carcinogenesis bioassay helps to evaluate carcinogenicity of the skin topically administered as will be clinical route.

We have applied above assays to Japanese authority.

Japanese

Medium-term Carcinogenesis Bioassay/Safety Assessment for Developing Products

DIMS Institute of Medical Science, Inc.

64 Goura, Nishiazai,
Azai-cho, Ichinomiya,
Aichi 491-0113, Japan

Tel: +81-586-51-1201
Fax: +81-586-51-5634

Company Profile

Mobile site

DIMS Institute of Medical Science, Inc.スマホサイトQRコード

Access to the mobile site of DIMS. from this QR code.